(Q38601304)

4 September 2017

1 reference

title

Lyme disease: of ticks and titers (English)

1 reference

4 September 2017

0 references

Eichenfield AH

1

1 reference

PubMed ID

2644410

4 September 2017

Athreya BH

series ordinal

2

1 reference

PubMed ID

2644410

4 September 2017

language of work or name

English

0 references

publication date

1 February 1989

1 reference

The Journal of Pediatrics

4 September 2017

1 reference

4 September 2017

114

1 reference

4 September 2017

2

1 reference

4 September 2017

328-333

1 reference

Childhood Lyme arthritis: experience in an endemic area

4 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

The clinical evolution of Lyme arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Lyme disease and its neurologic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Shulman syndrome, a scleroderma subtype caused by Borrelia burgdorferi?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Hepatitis Due to Recurrent Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Lyme myositis: muscle invasion by Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Fatal Adult Respiratory Distress Syndrome in a Patient With Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Histological evidence for spirochetal origin of morphea and lichen sclerosus et atrophicans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Cross-reactivity in serological tests for Lyme disease and other spirochetal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Enzyme-Linked Immunosorbent Assay and Indirect Immunofluorescence Assay for Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

The Spirochetal Etiology of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

An interlaboratory study of antibody to Borrelia burgdorferi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Correlation of Serum and Cryoglobulin IgM with Activity, and Serum IgG with Remission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Immune complexes and the evolution of Lyme arthritis. Dissemination and localization of abnormal C1q binding activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Borderline antibody response in initial stages of lymphocytic meningitis does not rule out borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Treatment of the Early Manifestations of Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Successful parenteral penicillin therapy of established Lyme arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2889%2980808-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(89)80808-X

1 reference

4 September 2017

1 reference

PubMed ID

2644410